91 related articles for article (PubMed ID: 8878551)
1. Mutations of E2F-4 trinucleotide repeats in colorectal cancer with microsatellite instability.
Yoshitaka T; Matsubara N; Ikeda M; Tanino M; Hanafusa H; Tanaka N; Shimizu K
Biochem Biophys Res Commun; 1996 Oct; 227(2):553-7. PubMed ID: 8878551
[TBL] [Abstract][Full Text] [Related]
2. E2F-4 mutation in hereditary non-polyposis colorectal cancer.
Moriyama H; Sasamoto H; Kambara T; Matsubara N; Ikeda M; Baba S; Meltzer SJ; Lynch HT; Shimizu K; Tanaka N
J Exp Clin Cancer Res; 2002 Jun; 21(2):185-9. PubMed ID: 12148576
[TBL] [Abstract][Full Text] [Related]
3. Mutational analysis of the transforming growth factor beta receptor type II gene in hereditary nonpolyposis colorectal cancer and early-onset colorectal cancer patients.
Shin KH; Park YJ; Park JG
Clin Cancer Res; 2000 Feb; 6(2):536-40. PubMed ID: 10690536
[TBL] [Abstract][Full Text] [Related]
4. Close correlation between mutations of E2F4 and hMSH3 genes in colorectal cancers with microsatellite instability.
Ikeda M; Orimo H; Moriyama H; Nakajima E; Matsubara N; Mibu R; Tanaka N; Shimada T; Kimura A; Shimizu K
Cancer Res; 1998 Feb; 58(4):594-8. PubMed ID: 9485005
[TBL] [Abstract][Full Text] [Related]
5. Various AGC repeat numbers in the coding region of the human transcription factor gene E2F-4.
Zhong X; Hemmi H; Koike J; Tsujita K; Shimatake H
Hum Mutat; 2000 Mar; 15(3):296-7. PubMed ID: 10679953
[TBL] [Abstract][Full Text] [Related]
6. Microsatellite instability is uncommon in breast cancer.
Anbazhagan R; Fujii H; Gabrielson E
Clin Cancer Res; 1999 Apr; 5(4):839-44. PubMed ID: 10213220
[TBL] [Abstract][Full Text] [Related]
7. Mutations of the transforming growth factor-beta type II receptor gene and genomic instability in hereditary nonpolyposis colorectal cancer.
Lu SL; Akiyama Y; Nagasaki H; Saitoh K; Yuasa Y
Biochem Biophys Res Commun; 1995 Nov; 216(2):452-7. PubMed ID: 7488133
[TBL] [Abstract][Full Text] [Related]
8. Frequent mutation of the E2F-4 cell cycle gene in primary human gastrointestinal tumors.
Souza RF; Yin J; Smolinski KN; Zou TT; Wang S; Shi YQ; Rhyu MG; Cottrell J; Abraham JM; Biden K; Simms L; Leggett B; Bova GS; Frank T; Powell SM; Sugimura H; Young J; Harpaz N; Shimizu K; Matsubara N; Meltzer SJ
Cancer Res; 1997 Jun; 57(12):2350-3. PubMed ID: 9192806
[TBL] [Abstract][Full Text] [Related]
9. Absence of mutations in the analysis of coding sequences of the entire transforming growth factor-beta type II receptor gene in sporadic human breast cancers.
Takenoshita S; Mogi A; Tani M; Osawa H; Sunaga H; Kakegawa H; Yanagita Y; Koida T; Kimura M; Fujita KI; Kato H; Kato R; Nagamachi Y
Oncol Rep; 1998; 5(2):367-71. PubMed ID: 9468559
[TBL] [Abstract][Full Text] [Related]
10. Significance of mutations in TGFBR2 and BAX in neoplastic progression and patient outcome in sporadic colorectal tumors with high-frequency microsatellite instability.
Fernández-Peralta AM; Nejda N; Oliart S; Medina V; Azcoita MM; González-Aguilera JJ
Cancer Genet Cytogenet; 2005 Feb; 157(1):18-24. PubMed ID: 15676142
[TBL] [Abstract][Full Text] [Related]
11. A transforming growth factor beta type II receptor gene mutation common in sporadic cecum cancer with microsatellite instability.
Togo G; Toda N; Kanai F; Kato N; Shiratori Y; Kishi K; Imazeki F; Makuuchi M; Omata M
Cancer Res; 1996 Dec; 56(24):5620-3. PubMed ID: 8971166
[TBL] [Abstract][Full Text] [Related]
12. Mutation of the transforming growth factor-beta type II receptor gene in right-sided colorectal cancer: relationship to clinicopathological features and genetic alterations.
Iacopetta BJ; Welch J; Soong R; House AK; Zhou XP; Hamelin R
J Pathol; 1998 Apr; 184(4):390-5. PubMed ID: 9664904
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic pathway of sporadic colorectal cancer with novel germline missense mutations in the hMSH2 gene.
Yamada K; Zhong X; Kanazawa S; Koike J; Tsujita K; Hemmi H
Oncol Rep; 2003; 10(4):859-66. PubMed ID: 12792735
[TBL] [Abstract][Full Text] [Related]
14. Mutation analysis of the transforming growth factor-beta type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-beta.
Vincent F; Nagashima M; Takenoshita S; Khan MA; Gemma A; Hagiwara K; Bennett WP
Oncogene; 1997 Jul; 15(1):117-22. PubMed ID: 9233784
[TBL] [Abstract][Full Text] [Related]
15. Mutation analysis of the transforming growth factor beta type II receptor in sporadic human cancers of the pancreas, liver, and breast.
Vincent F; Hagiwara K; Ke Y; Stoner GD; Demetrick DJ; Bennett WP
Biochem Biophys Res Commun; 1996 Jun; 223(3):561-4. PubMed ID: 8687435
[TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of TGF-beta type II receptor, Smad2, Smad3, Smad4, Smad6 and Smad7 genes in colorectal cancer.
Fukushima T; Mashiko M; Takita K; Otake T; Endo Y; Sekikawa K; Takenoshita S
J Exp Clin Cancer Res; 2003 Jun; 22(2):315-20. PubMed ID: 12866583
[TBL] [Abstract][Full Text] [Related]
17. HMSH6 alterations in patients with microsatellite instability-low colorectal cancer.
Parc YR; Halling KC; Wang L; Christensen ER; Cunningham JM; French AJ; Burgart LJ; Price-Troska TL; Roche PC; Thibodeau SN
Cancer Res; 2000 Apr; 60(8):2225-31. PubMed ID: 10786688
[TBL] [Abstract][Full Text] [Related]
18. A dominant negative mutation of transforming growth factor-beta receptor type II gene in microsatellite stable oesophageal carcinoma.
Tanaka S; Mori M; Mafune K; Ohno S; Sugimachi K
Br J Cancer; 2000 May; 82(9):1557-60. PubMed ID: 10789724
[TBL] [Abstract][Full Text] [Related]
19. Microsatellite instability and gene mutations in transforming growth factor-beta type II receptor are absent in small bowel carcinoid tumors.
Kidd M; Eick G; Shapiro MD; Camp RL; Mane SM; Modlin IM
Cancer; 2005 Jan; 103(2):229-36. PubMed ID: 15599934
[TBL] [Abstract][Full Text] [Related]
20. Microsatellite alterations and target gene mutations in the early stages of multiple gastric cancer.
Ogata S; Tamura G; Endoh Y; Sakata K; Ohmura K; Motoyama T
J Pathol; 2001 Jul; 194(3):334-40. PubMed ID: 11439366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
